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ABSTRACT 
Introduction 
Characterising how physical and psychological symptoms interact in heart transplant 
recipients may lead to advances in therapeutic options. The aim of this study was to 
examine associations between pain and major depression.  
Methods 
A cross-sectional study was conducted with adult heart transplant recipients. Pain was 
measured with the bodily pain domain of the Medical Outcomes Short Form-36 item health 
survey, psychological distress was measured with the Kessler Psychological Distress 10-item 
Scale (K-10) and a structured psychological interview (Mini International Neuropsychiatric 
Interview Version 6) was used to identify who met the criteria for major depression. 
Hierarchical linear regression was used to determine if there was an association between 
pain and major depression, controlling for pharmacological treatment of depression, 
severity of psychological distress and clinical characteristics including immunosuppression 
medication. 
Results 
Average pain score of the 48 heart transplant recipients was 43 (SD±10; range 0-100; lower 
scores indicate worse pain), moderate pain was reported by 39% (n=19). Major depression 
was associated with worse pain (R2 change=36%; β=-16; 95% CI=-30 to -4; p=.012). 
Pharmacological treatment for depression was associated with better pain scores (R2 
change=1.5%; β=13; 95% CI=4 to 23; p=.006).   
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Conclusions 
We identified that heart transplant recipients with major depression had worse pain after 
controlling for pharmacological treatment of depression, severity of psychological distress 
and clinical characteristics including the medications used for immunosuppression, which 
are known to induce pain as a side effect. Thus, it is imperative that clinicians devising a 
treatment regimen for pain in heart transplant recipients take in to account co-occurring 
depression, and vice versa.   
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Introduction 
Heart transplantation results in better long-term survival than alternative end-stage heart 
failure treatments (Daneshmand et al., 2010; Haddad et al., 2004). On average, heart 
transplantation also markedly improves functional status and overall quality of life (Aravot, 
Berman, Ben-Gal, Sahar, & Vidne, 2000). However, for many heart transplant recipients, 
transplantation and other related comorbidities imposes a significant and life-long physical 
and psychological symptom burden. 
For example, depression is common after heart transplant (Dew & DiMartini, 2006; 
McCrystal, Pepe, Esmore, & Rosenfeldt, 2004; Politi et al., 2004; Taylor, Stehlik, & Edwards, 
2009). A recent study reported that the estimated frequency of major depression within five 
years after heart transplantation was 41% (Favaro et al., 2011). Post-transplant depression 
has been associated with increased morbidity and mortality (Dew et al., 1999).  Of concern, 
effective treatments to prevent or alleviate depressive symptoms in heart transplant 
recipients remain elusive (Conway et al., 2014; Fusar-Poli et al., 2006). Physical symptoms 
can also be severe and distressing for heart transplant recipients, which arise from the 
adverse effects of immunosuppression medication as well as comorbidities.   
Better characterisation of how physical and psychological symptoms interact in heart 
transplant recipients may inform therapeutic decisions, as the effectiveness of treatment 
may be influenced by the impact of other symptoms. For example, it is possible that 
interventions targeting a physical symptom could simultaneously improve symptoms of co-
occurring depression, and vice versa.  
A previous investigation identified that 46% of a sample of 92 adult outpatient heart 
transplant recipients reported at least mild pain. (Holtzman, Abbey, Stewart, & Ross, 2010) 
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It was noted by the authors of this study that further research into associations between 
pain and psychiatric comorbidity in this population was required. As a preliminary step 
towards addressing this gap in knowledge about physical and psychological symptoms 
interactions in heart transplant recipients, the present study aimed to examine the 
associations between major depression and pain in heart transplant recipients.  
Methods 
This study used a cross-sectional design. The ethics committees of the participating 
institutions approved the study (HREC13QPCH239; 1300000686). All participants provided 
informed consent to participate. 
Participants 
Heart transplant recipients over 18 years of age who attended the outpatient clinic at a 
major metropolitan hospital in Australia were eligible to participate in the study. Patients 
who were less than three months post-transplant as well as those who were cognitively 
impaired (as confirmed by a treating clinician), unable to understand and speak English, had 
a diagnosed major psychiatric comorbidity (schizophrenia, bipolar disorder, dementia) or 
terminal illness were excluded. 
Data collection 
Data concerning demographics and clinical characteristics were collected from medical 
records. Symptom experience data were collected from participants using self-report 
questionnaires. Questionnaires were completed by participants while waiting for their 
appointment at the outpatient clinic. A research assistant was available to provide 
clarification about any of the items contained within the questionnaire. A structured 
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psychological interview was conducted by a provisional psychologist undertaking a Doctor of 
Clinical Psychology degree.  
Measures 
Medical Outcomes Short Form-36 Health Survey (SF-36) 
The SF-36 is a widely used generic patient assessed health outcome measure (Garratt, 
Schmidt, Mackintosh, & Fitzpatrick, 2002). It yields an 8-scale profile of self-reported 
functional health and well-being. Only scores from the ‘bodily pain’ domain were included in 
this analysis. This domain includes two items that measure pain severity (rated as ‘none’, 
‘very mild’, ‘mild’, ‘moderate’, ‘severe’ and ‘very severe’) and pain interference (rated as 
‘not at all’ to ‘extremely’ interfering with normal work) over the preceding month. 
Responses to both items are converted to an overall domain score that ranges from 0 to 100 
with lower scores indicating worse pain. The pain-specific patient-reported outcome 
measurement, the brief pain inventory, was shown to exhibit similar relationships to general 
and condition-specific measures of health as did the generic SF-36 pain scale (Keller et al., 
2004).  
Kessler Psychological Distress Scale (K-10) 
The Kessler Psychological Distress Scale (K-10) is a brief self-report measure of psychological 
distress, which is used frequently in research and clinical practice to screen for psychological 
disorders. This 10-item scale measures severity of anxiety and depression symptoms using a 
5-point Likert type scale. It has been shown to strongly discriminate between community 
cases and non-cases of DSM-IV psychological disorders (Kessler et al., 2002). 
Mini International Neuropsychiatric Interview version 6.0 (MINI 6.0) 
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The MINI 6.0 is a short structured diagnostic interview for DSM-IV and ICD-10 psychiatric 
disorders (Sheehan et al., 1998). It consists of 120 questions and screens 17 axis I disorders 
for 24 current and lifetime diagnoses. Only the Major Depression (Current) module was 
used for this analysis. 
Statistical analysis 
Descriptive statistics were generated using IBM SPSS Statistics version 21 (IBM Corp., 
Armonk, NY). Frequencies, means and standard deviations (SD) were used to describe 
demographic, clinical and symptom characteristics. Associations between pain, major 
depression and pharmacological treatment for depression were examined using hierarchical 
multiple regression. Major depression was defined according to DSM-IV criteria based on a 
structured psychological interview performed using the MINI. Age (years), gender, time 
since transplant (years), number of medical comorbidities, presence of chronic allograft 
vasculopathy, presence of an oncology illness, medications for immunosuppression and 
severity of psychological distress measured using the K10 were entered in the first block. 
Pharmacological treatment for depression was entered in the second block. Major 
depression was entered in the third block. Regression diagnostics, including checks for 
normality of residuals, multicollinearity, linearity, heteroscedasticity and model 
specification, confirmed the data met the underlying assumptions for regression. 
Results 
From January to September 2014, 122 of the 126 (97%) heart transplant recipients who 
were screened on their attendance at the outpatient clinic met the study eligibility criteria. 
A total of 48 (40%) chose to participate and completed all measures required for this 
analysis (MINI and pain domain of the SF-36). The sample consisted mostly of long-term 
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survivors of heart transplantation (median 9 years post-transplant) and was predominantly 
male (n=37; 76%). An overview of demographic and clinical characteristics is presented in 
Table 1.  
Depression and pain scores 
Five participants (10%) met criteria for major depression based on a structured 
psychological interview performed using the MINI. Nine participants (18%) were currently 
receiving pharmacological treatment for depression including two participants (40%) who 
met criteria for major depression. Average score on the bodily pain domain of the SF-36 was 
worse in the major depression group (mean 37; SD 11) and better in the group who received 
pharmacological treatment for depression (mean 50; SD 9) compared with the overall 
sample (mean 43; SD 10). At least moderate pain was reported by 39% (n=19) of the sample. 
Association between pain and depression  
Hierarchical multivariable linear regression was used to examine associations between 
major depression, pharmacological treatment for depression and pain (Table 2). 
Pharmacological treatment for depression was associated with better pain scores, but 
explained only 1.5% of the variance. Major depression was associated worse pain, 
explaining 36.3% of the variance. The final model explained 46.9% of the variance in pain 
scores.  
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Discussion 
From a clinical perspective, recognition of the physical symptoms that co-occur with major 
depression in heart transplant recipients is important considering how difficult it is to treat 
this condition. We identified that heart transplant recipients with major depression had 
worse pain after controlling for pharmacological treatment of depression, severity of 
psychological distress and clinical characteristics including the medications used for 
immunosuppression, which are known to induce pain as a side effect (Dobbels et al., 2008). 
A difference in score of 10-20 in the pain domain of the SF-36 corresponds to a small to 
moderate clinically important difference (Wyrwich, Tierney, Babu, Kroenke, & Wolinsky, 
2005). Therefore, our findings would indicate that the impact of major depression on pain in 
heart transplant recipients is also clinically significant. We further identified that receiving 
pharmacological treatment for depression was associated with better pain scores.  Our 
results are consistent with previous research, as both pain and depression are prevalent in 
other transplant populations (Koller et al., 2010). Research in non-transplant populations 
has also identified that pain and depression commonly co-occur (Chou, 2007; Doering, Chen, 
McGuire, Bodán, & Irwin, 2014; Onder et al., 2005).  
It is unknown whether pain preceded the onset of major depression in the patients included 
in our study. However, previous research has identified that pain is a risk factor for 
depression.11 For this reason, early identification of pain and initiation of interventions to 
alleviate this symptom may prevent the development of major depression in heart 
transplant recipients. We also did not investigate the underlying pathology for pain in our 
study. Previous research in other transplant populations also identified a high prevalence of 
pain. For example, Moons et al. (2003) reported that more than half of a cohort of 350 renal 
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transplant recipients experienced pain. Likewise, Koller et al. (2010) found that fatigue and 
pain were the most frequent and distressing symptoms experienced by 356 renal transplant 
recipients. These previous studies also did not identify causes of the pain. It is therefore 
unknown whether pain in this population is related, for example, to adverse effects 
immunosuppressive regimens or age-related degenerative musculoskeletal changes (Koller 
et al., 2010). For this reason, further research focused on characterising the underlying 
causes of pain in transplant recipients, both in general as well as for heart transplant 
recipients specifically, may be beneficial in order to inform treatment options. Likewise, it 
should be noted that the antecedents of major depression were not examined in this study. 
The development of this condition was likely influenced by the unique experience of end-
stage heart failure and subsequent transplantation, which is highly traumatic. Trauma is 
associated with the subsequent development of major depression as well as worse 
cardiovascular health (Felitti et al., 1998). It has also been identified that competing senses 
of hope and gratitude mixed with guilt and grief regarding the acceptance of a heart from a 
deceased donor may contribute to psychopathology in this population (Conway et al., 
2013). More research into how depression manifests after heart transplantation is required 
in order to determine the most effective supportive strategies.  
Several biological and behavioural mechanisms might explain the co-occurrence of pain and 
major depression that we observed (Bair, Robinson, Katon, & Kroenke, 2003; Williams, 
Jacka, Pasco, Dodd, & Berk, 2006). For example, it has been posited that the deficiencies in 
the neurotransmitters serotonin and norepinephrine associated with depression may also 
result in a reduced ability of these neurotransmitters to dampen peripheral pain signals 
(Bair et al., 2003). A potential mechanism for the development of depression in people who 
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experience pain over a prolonged period of time is that it triggers stress responses that 
leads to dysregulation of the hypothalamus-pituitary-adrenal axis and results in depression 
(Williams et al., 2006). Other hypotheses about the aetiology of the pain and depression 
comorbidity focus more on the behavioural implications of pain or decreased mood and vice 
versa. For example,  greater levels of life interference caused by symptoms of pain was 
found to be associated with higher levels of depression (Endler, Corace, Summerfeldt, 
Johnson, & Rothbart, 2003). As results from our study are consistent with this broader 
literature about the physical experience of depression, it would suggest that the core 
symptoms within the identified cluster could result from interactive psychological, 
physiological or behavioural mechanisms. 
Pharmacological treatment for depression was associated with better pain scores, 
suggesting a potential additional benefit of this form of therapy. However, the potential for 
a responder bias should be noted. We did not examine whether or not those patients who 
had major depression had previously been prescribed anti-depressive pharmacological 
therapies and had since stopped taking this medication due to ineffectiveness. On a related 
note, it is unknown whether or not non-pharmacological treatments for depression, such as 
cognitive behavioural therapy, influence pain in the heart transplant population. This is an 
area that could be considered for investigation in the future. 
Despite being recommended in clinical guidelines, regular screening for depression is not 
currently standard practice in all institutions (Costanzo et al., 2010). In this regard, at 
institutions that do not routinely screen for depression, it may be beneficial for clinicians to 
conduct a more formal evaluation for psychopathology in transplant recipients who report 
pain. 
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A limitation of this study to note is the potential for selection bias, arising from the non-
randomised design and low response rate. Also, due to the sample for this study being 
predominantly long-term survivors of heart transplantation, results should not be 
generalised outside of this context. Further research with a larger sample size is required to 
increase confidence in the results. Moreover, a longitudinal design would be preferable in 
any future studies so that the relationship between major depression and pain could be 
determined over time. A longitudinal design would permit analyses to determine whether 
the co-occurrence of major depression and pain exerts a synergistically negative impact on 
clinical outcomes for heart transplant recipients by tracking morbidity and mortality. It 
should also be noted that the pain domain of the SF-36 provides a composite measure of 
pain severity and its interference with normal daily activities. It may be that, although 
experienced frequently, pain may not have been distressing for all participants. 
Furthermore, those participants who were more able to cope with symptoms of pain (i.e. 
rated them as causing less interference), may also have been less likely to also have 
depressive symptoms.  Further research investigating these potential interactions with 
depression may be beneficial.  
In conclusion, our results are consistent with the broader literature about the physical 
experience of depression. Thus, it is imperative that clinicians devising a treatment regimen 
for pain in heart transplant recipients take in to account co-occurring depression, and vice 
versa.   
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Table 1 Demographic, symptom and clinical characteristics 
Variable Mean (SD),  
Median (IQR) or Count 
(%) 
Total n=48 
Mean (SD), 
Median (IQR) or 
Count (%) 
Major depression 
n=5 
Mean (SD), Median 
(IQR) or Count (%) 
Pharmacological 
treatment for 
depression  
n=9 
Age 63 (55,67) 54(35,63) 65(54,71) 
Male 37 (76) 3(60) 5(56) 
Time since transplant (years) 9(2.5, 18) 11(9,11) 18(7,18) 
Ischaemic aetiology of heart 
failure 
15 (31) 1(20) 2(22) 
Cancer (including skin cancer) 19 (39) 0(0) 5(56) 
Current acute rejection 0 (0) 0 (0) 0 (0) 
Number of comorbidities  7(4,8) 7(7,8) 8(7,10) 
Currently taking steroid 24 (50) 2(40) 4(44) 
Currently taking anti-
depressive medications 
9 (18) 2(40) 9(100) 
K10 total score (higher score 
indicates more severe 
psychological distress) 
15(6) 26(9) 21(10) 
Pain domain score in SF-36  
(ranges from 0-100 with a 
lower score indicating worse 
pain) 
43(10) 37(11) 
 
50(9) 
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Table 2 Associations between pain, depression and depression treatmenta 
Model  R2 R2 Changea F Change Sig 
Step 1  .091    
Step 2   .107 .015 1.072 .305 
Step 3   .469 .363 18.601 .000 
    95% confidence interval 
for β 
Variables in equation at step 3 β t Significance Lower Upper 
(constant) 40.503 1.12 .271 -33.137 114.143 
Age (years) -.131 -.890 .378 -.429 .167 
Time since transplant (years) .033 .410 .681 -.128 .194 
Gender -2.200 -.690 .681 -8.661 4.261 
Steroid 2.929 .970 .338 -3.214 9.073 
Cyclosporin 4.177 .830 .412 -6.065 14.419 
Azathropine -2.383 -.310 .756 -17.884 13.118 
Sirolimus 4.581 .880 .384 -5.990 15.152 
Everolimus -10.539 -1.630 .113 -23.727 2.649 
Tacrolimus 13.072 2.26 .031 1.299 24.845 
Mycophenolate -10.165 -1.38 .178 -25.200 4.869 
Number of comorbidities -.255 -.390 .698 -1.586 1.076 
Cancer 1.677 .450 .655 -5.897 9.251 
Severity of psychological distress 
(K10 score) 
.342 1.05 .301 -.320 1.003 
Anti-depressive medication 13.401 2.96 .006 4.172 22.631 
Major depression (assessed with 
MINI) 
-16.891 -2.66 .012 -29.844 -3.939 
aLinear regression, pain domain of SF-36 is the dependent variable; MINI=Mini International 
Neuropsychiatric Interview; K10=Kessler 10 item Psychological Distress scale 
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